SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
28 hedge funds and large institutions have $93.4M invested in Sinovac Biotech, Ltd in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
28
Holding in Top 10
2
Calls
$289K
Puts
$300K
Top Buyers
| 1 | +$45M | |
| 2 | +$460K | |
| 3 | +$275K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$170K |
| 5 |
YMRC
Yorktown Management & Research Company
Forest,
Virginia
|
+$39.6K |
Top Sellers
| 1 | -$649K | |
| 2 | -$547K | |
| 3 | -$216K | |
| 4 |
SG Americas Securities
New York
|
-$179K |
| 5 |
State Street
Boston,
Massachusetts
|
-$87.6K |